Name: #AskDrDurie: Will any of the newly FDA-approved drugs be available for frontline therapy?
Uploaded: 2016-02-19T11:54:02-0800
Duration: 4 min 31 s
Description: In this week's video, Dr. Brian G.M. Durie discusses if the newly FDA-approved drugs (Ninlaro, Empliciti, Darzalex) be available for frontline therapy? Bottom Line: When to use the new drugs requires a case-by-case discussion, with possible use in early disease stages.

In this week's video, Dr. Brian G.M. Durie discusses if the newly FDA-approved drugs (Ninlaro, Empliciti, Darzalex) be available for frontline therapy?

Bottom Line:

When to use the new drugs requires a case-by-case discussion, with possible use in early disease stages.

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.